Issue
Number 315
May 28, 2002
CONTENTS OF THIS ISSUE
- FDA approves new
DTaP vaccine product
- New "Pink Book" from
CDC is available in print and online
- National
Immunization Program gives latest influenza
vaccine ordering information for 2002-2003
season
- Coming up in July:
National Leadership Summit to Eliminate Racial
and Ethnic Disparities in Health
- Teleclinics on
tetanus prophylaxis and wound management are
scheduled for May 30, May 31, and June 11
----------------------------------------------------------
Back to Top
(1 of 5)
May 28, 2002
FDA APPROVES NEW DTAP VACCINE PRODUCT
On May 14, 2002, the U.S. Food and Drug Administration
(FDA) approved DAPTACEL (tm), which
contains diphtheria and tetanus toxoids and
acellular pertussis vaccine adsorbed (DTaP), for
distribution in the United States.
DAPTACEL (tm) is a product of Aventis Pasteur Limited in
Toronto, Ontario.
DAPTACEL is thimerosal-free. It joins Tripedia and
Infanrix in the U.S. market for DTaP vaccines for
infants and children. DAPTACEL is indicated for
immunization against diphtheria, tetanus, and
pertussis in infants aged
6 weeks through children aged 6 years (up to 7th birthday).
To see the Product Approval Information--Licensing Action
for DAPTACEL on the FDA website, go to:
http://www.fda.gov/cber/products/dtapave051402.htm
----------------------------------------------------------
Back to Top
(2 of 5)
May 28, 2002
NEW "PINK BOOK" FROM CDC IS AVAILABLE IN PRINT AND ONLINE
The 7th edition of "Epidemiology and Prevention of
Vaccine-Preventable Diseases," widely known as the
"Pink Book," is now available both in print for purchase and
online for free downloading. The 6th
edition was published by the Centers for Disease
Control and Prevention (CDC) in January 2000 and
updated in January 2001.
The "Pink Book" is an easy-to-read, quick reference work
for clinics and other health care settings. It
deserves a place on every "immunization
bookshelf." Highlights of the 7th edition include
a revised chapter on general vaccine
recommendations, new chapters on smallpox and anthrax
vaccines, and an appendix devoted to
vaccine administration.
The cost of the "Pink Book" is $25 plus shipping and handling.
To order a copy, choose one of the
following methods: call (877) 252-1200 between
9:00 a.m. and 5:00 p.m. ET; send a fax order with
credit card or purchase order information to
(301) 843-0159; or visit the Public Health Foundation
(PHF) bookstore at:
http://bookstore.phf.org/prod171.htm
To print a camera-ready (PDF format) copy of the entire
"Pink Book" or selected chapters, go to:
http://www.cdc.gov/nip/publications/pink/
----------------------------------------------------------
Back to Top
(3 of 5)
May 28, 2002
NATIONAL IMMUNIZATION PROGRAM GIVES LATEST INFLUENZA
VACCINE ORDERING INFORMATION FOR 2002-2003
SEASON
On May 10, 2002, CDC's National Immunization Program (NIP)
published the second in this year's
annual series of influenza bulletins designed to
update health professionals on the production,
distribution, and administration of
influenza vaccine.
According to the bulletin, production of influenza vaccine
for 2002-2003, at approximately 90 million
doses, is estimated to be slightly higher than
last year's production.
Of special note are two items: (1) "CDC published the 2002
influenza vaccine recommendations of the
Advisory Committee on Immunization Practices (ACIP)
on April 12" (see IAC EXPRESS #306 at
http://www.immunize.org/genr.d/issue306.htm) and
(2) "Influenza vaccine for the 2002-2003 influenza
season is still available for purchase."
The bulletin states that Aventis-Pasteur is
completely prebooked for influenza
vaccine, but two other suppliers continue to take orders.
- Evans Vaccines influenza vaccine may be
purchased through FFF Enterprises by phone at
(800) 843-7477 or fax at
(800) 418-4333. To order online, go to:
http://www.fluvaccine.net
- Wyeth influenza vaccine may be ordered by phone at
(800) 358-7443
To read Influenza Bulletin #2, go to:
http://www.immunize.org/news.d/flubull2.pdf
----------------------------------------------------------
Back to Top
(4 of 5)
May 28, 2002
COMING UP IN JULY: NATIONAL LEADERSHIP SUMMIT TO ELIMINATE
RACIAL AND ETHNIC DISPARITIES IN HEALTH
Registration is still open for the National Leadership
Summit to Eliminate Racial and Ethnic Disparities in
Health, scheduled for July 10-12, 2002, at the Hilton
Hotel and Towers in Washington, D.C. The summit
is sponsored by the Office of Minority
Health (OMH) within the U.S. Department of Health
and Human Services (DHHS).
The Leadership Summit seeks to draw national attention to
the existence of health disparities and to
innovative approaches being implemented at the
local, state, federal, and tribal levels.
The summit will be organized around three major "tracks":
(1) access to care; (2) health professions;
and (3) research and data. The issue of
culturally and linguistically appropriate services
will be incorporated into the five plenary
sessions and 80 workshops.
The registration fee for the summit is $150. On-site
registration will not be available.
For more information on registering, exhibiting, or
applying for a poster session, call (888) 516-5599 or
visit
http://www.summit.omhrc.gov
----------------------------------------------------------
Back to Top
(5 of 5)
May 28, 2002
TELECLINICS ON TETANUS PROPHYLAXIS AND WOUND MANAGEMENT
ARE SCHEDULED FOR MAY 30, MAY 31, AND JUNE
11
The interactive teleclinic "Tetanus Prophylaxis and Wound
Management: Update on Prevention,
Diagnosis, and Treatment of Tetanus" will be held
this Thursday, May 30, at 5:00p.m. ET, and this
Friday, May 31, at 11:00 a.m ET. Another session will
be held on Tuesday, June 11, at 12:00 noon ET.
Participants may earn 1.5 continuing
medical education (CME) or nursing contact hours.
The presenters of the TeleClinic are David Talan, M.D.,
F.A.C.E.P., F.I.D.S.A., Professor of Medicine,
UCLA School of Medicine and Erwin W.
Gelfand, M.D., Professor of Pediatrics and
Immunology, University of Colorado Health
Sciences Center, Denver.
To register for a TeleClinic online, go to:
http://www.interactiveteleclinics.com/TPWM_contact.shtml
To register for a TeleClinic by phone, call (800) 870-8376.
|
